Welcome to our dedicated page for Acacia Resh SEC filings (Ticker: ACTG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Acacia Research Corporation (Nasdaq: ACTG) SEC filings page on Stock Titan provides access to the companys regulatory disclosures, together with AI-generated summaries that help explain the content of each document. Acacia files periodic and current reports with the U.S. Securities and Exchange Commission as a Nasdaq-listed issuer.
Investors can review quarterly and annual reports, where Acacia presents consolidated financial statements and segment information for Energy Operations (Benchmark), Industrial Operations (Printronix), Manufacturing Operations (Deflecto) and Intellectual Property Operations (Acacia Research Group). These filings expand on topics highlighted in earnings releases, such as revenue composition, non-GAAP measures like Total Company Adjusted EBITDA and Operated Segment Adjusted EBITDA, and details of acquisitions and investments.
The filings page also includes Form 8-K current reports that Acacia uses to disclose material events. Recent examples referenced in the input include 8-Ks announcing quarterly financial results and the appointment of a Chief Financial Officer, along with a summary of the related employment agreement and indemnification arrangements. AI summaries on Stock Titan highlight the key items in each 8-K so readers can quickly understand what changed and why it matters.
Users interested in capital structure and investment activity can turn to Acacias SEC reports for information on cash, cash equivalents, equity securities, loans receivable and equity method investments, including its indirect stake in Viamet Pharmaceuticals, Inc. through MalinJ1. The filings also describe loans receivable that represent commercial loans collateralized by Bitcoin, connected to Acacias partnership with Unchained Capital.
Stock Titans interface surfaces these documents as they are posted to EDGAR and applies AI to summarize complex sections, helping readers navigate topics such as segment performance, non-GAAP reconciliations, executive arrangements and risk disclosures without having to parse every line of the underlying forms.
Zambito Michael SIKORYAK, identified on the filing as the issuer's Chief Financial Officer, reported a purchase of 7,700 shares of Acacia Research Corporation (ACTG) on 08/11/2025. The transaction was coded P for a purchase and was executed at a weighted average price of $3.2658, with the filing noting component trades priced between $3.25 and $3.32. Following the transaction the reporting person beneficially owned 7,700 shares in a direct capacity.
The Form 4 was signed by an attorney-in-fact, Jennifer Graff, on 08/12/2025. No derivative transactions or other securities classes are reported on this filing, and no amendments or additional material items are included.
Michelle Felman, identified as a director of Acacia Research Corporation (ACTG), reported two gift transactions of company common stock dated 08/11/2025. The filing states she gifted 11,560 shares and 11,561 shares to an irrevocable trust established for the benefit of her son, and that each gift was for no consideration.
The Form 4 shows the transactions coded as gifts and reports post-transaction direct beneficial ownership figures of 43,733 shares and 32,172 shares respectively as listed on the form. The filing is signed by an attorney-in-fact.